Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soft Tissue Neoplasms | 17 | 2024 | 1151 | 2.980 |
Why?
|
Sarcoma | 14 | 2023 | 1786 | 2.760 |
Why?
|
Bone Neoplasms | 17 | 2023 | 2532 | 2.130 |
Why?
|
Sarcoma, Synovial | 4 | 2023 | 151 | 1.670 |
Why?
|
Pleural Effusion | 3 | 2021 | 343 | 1.520 |
Why?
|
Cytodiagnosis | 4 | 2019 | 432 | 1.170 |
Why?
|
Osteosarcoma | 6 | 2023 | 898 | 1.060 |
Why?
|
Cyst Fluid | 2 | 2018 | 83 | 1.040 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.900 |
Why?
|
Pancreatic Cyst | 3 | 2018 | 367 | 0.880 |
Why?
|
Fibromatosis, Aggressive | 1 | 2024 | 125 | 0.840 |
Why?
|
Synovial Cyst | 2 | 2022 | 35 | 0.810 |
Why?
|
Abdominal Fat | 1 | 2024 | 223 | 0.790 |
Why?
|
Fibroma, Ossifying | 1 | 2021 | 14 | 0.790 |
Why?
|
Biopsy, Fine-Needle | 9 | 2024 | 1111 | 0.780 |
Why?
|
Immunohistochemistry | 11 | 2024 | 11064 | 0.760 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2021 | 52 | 0.760 |
Why?
|
RNA-Binding Protein EWS | 6 | 2024 | 210 | 0.760 |
Why?
|
Sarcoma, Kaposi | 1 | 2024 | 376 | 0.740 |
Why?
|
Chordoma | 6 | 2020 | 346 | 0.720 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1591 | 0.710 |
Why?
|
Pleural Effusion, Malignant | 1 | 2021 | 103 | 0.710 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2020 | 53 | 0.680 |
Why?
|
Ascitic Fluid | 1 | 2019 | 189 | 0.660 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 67 | 0.660 |
Why?
|
beta Catenin | 1 | 2024 | 1043 | 0.640 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3618 | 0.630 |
Why?
|
Body Fluids | 1 | 2019 | 319 | 0.600 |
Why?
|
Amyloidosis | 2 | 2024 | 818 | 0.590 |
Why?
|
Pericardial Effusion | 1 | 2019 | 247 | 0.580 |
Why?
|
In Situ Hybridization | 6 | 2021 | 1900 | 0.560 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2017 | 125 | 0.540 |
Why?
|
Sarcoma, Small Cell | 1 | 2016 | 17 | 0.530 |
Why?
|
Adenocarcinoma | 4 | 2023 | 6310 | 0.510 |
Why?
|
Mucin-4 | 1 | 2014 | 33 | 0.490 |
Why?
|
Lung Transplantation | 1 | 2024 | 1304 | 0.480 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5333 | 0.470 |
Why?
|
Fasciitis | 1 | 2014 | 66 | 0.450 |
Why?
|
Diagnosis, Differential | 11 | 2024 | 12968 | 0.430 |
Why?
|
Liposarcoma | 3 | 2020 | 283 | 0.410 |
Why?
|
Joint Diseases | 1 | 2016 | 458 | 0.400 |
Why?
|
Preoperative Period | 1 | 2014 | 555 | 0.400 |
Why?
|
Pancreas | 2 | 2020 | 1677 | 0.400 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 917 | 0.380 |
Why?
|
Sciatic Nerve | 1 | 2014 | 612 | 0.370 |
Why?
|
Spine | 1 | 2018 | 1111 | 0.370 |
Why?
|
Calcinosis | 4 | 2022 | 1478 | 0.370 |
Why?
|
Splenic Neoplasms | 1 | 2010 | 96 | 0.340 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2022 | 155 | 0.340 |
Why?
|
Epithelioid Cells | 3 | 2020 | 60 | 0.340 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2022 | 117 | 0.340 |
Why?
|
Pathology, Clinical | 1 | 2013 | 375 | 0.340 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2010 | 83 | 0.340 |
Why?
|
Neurilemmoma | 1 | 2015 | 523 | 0.330 |
Why?
|
Hemangiosarcoma | 2 | 2023 | 218 | 0.320 |
Why?
|
Gene Rearrangement | 5 | 2020 | 1122 | 0.320 |
Why?
|
RANK Ligand | 2 | 2020 | 318 | 0.310 |
Why?
|
Skull Neoplasms | 2 | 2019 | 173 | 0.300 |
Why?
|
Humans | 81 | 2024 | 760261 | 0.290 |
Why?
|
Adenoma | 2 | 2009 | 2148 | 0.290 |
Why?
|
Carcinoma in Situ | 1 | 2013 | 796 | 0.290 |
Why?
|
Knee Joint | 1 | 2016 | 1662 | 0.290 |
Why?
|
Fibrosarcoma | 2 | 2023 | 308 | 0.290 |
Why?
|
Chondrosarcoma | 2 | 2023 | 296 | 0.290 |
Why?
|
Middle Aged | 43 | 2024 | 220175 | 0.280 |
Why?
|
Male | 48 | 2024 | 359413 | 0.270 |
Why?
|
Aged | 33 | 2024 | 168995 | 0.270 |
Why?
|
Adult | 39 | 2024 | 219847 | 0.270 |
Why?
|
Endometrial Neoplasms | 2 | 2018 | 1361 | 0.260 |
Why?
|
Cell Nucleus | 1 | 2015 | 2909 | 0.260 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2009 | 325 | 0.260 |
Why?
|
Aged, 80 and over | 16 | 2024 | 58947 | 0.250 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13249 | 0.250 |
Why?
|
Gastroplasty | 1 | 2007 | 157 | 0.250 |
Why?
|
Female | 47 | 2024 | 391011 | 0.250 |
Why?
|
Staining and Labeling | 3 | 2024 | 1090 | 0.240 |
Why?
|
Neoplasm Metastasis | 3 | 2018 | 4891 | 0.240 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2024 | 33 | 0.240 |
Why?
|
Fibroma | 2 | 2018 | 190 | 0.240 |
Why?
|
Congo Red | 1 | 2024 | 48 | 0.240 |
Why?
|
Observer Variation | 2 | 2024 | 2596 | 0.220 |
Why?
|
Young Adult | 18 | 2021 | 58673 | 0.210 |
Why?
|
Cyclin D1 | 1 | 2024 | 453 | 0.200 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1266 | 0.200 |
Why?
|
Granuloma, Giant Cell | 1 | 2021 | 32 | 0.200 |
Why?
|
Prognosis | 11 | 2023 | 29636 | 0.200 |
Why?
|
Sarcoma, Clear Cell | 1 | 2022 | 72 | 0.200 |
Why?
|
Lymph Nodes | 1 | 2013 | 3491 | 0.200 |
Why?
|
Clone Cells | 2 | 2022 | 1663 | 0.190 |
Why?
|
Giant Cells | 1 | 2021 | 185 | 0.190 |
Why?
|
Chondroblastoma | 1 | 2020 | 48 | 0.180 |
Why?
|
Artifacts | 1 | 2009 | 1893 | 0.180 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1293 | 0.180 |
Why?
|
Thyroid Neoplasms | 2 | 2015 | 2332 | 0.180 |
Why?
|
Oncogene Fusion | 1 | 2020 | 81 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2019 | 368 | 0.170 |
Why?
|
STAT6 Transcription Factor | 1 | 2020 | 193 | 0.170 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 122 | 0.170 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2020 | 104 | 0.170 |
Why?
|
Protein Isoforms | 1 | 2024 | 1697 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8498 | 0.170 |
Why?
|
Fibroma, Desmoplastic | 1 | 2019 | 6 | 0.170 |
Why?
|
Neurofibrosarcoma | 1 | 2019 | 26 | 0.170 |
Why?
|
Exudates and Transudates | 1 | 2019 | 175 | 0.160 |
Why?
|
Amyloid | 1 | 2024 | 843 | 0.160 |
Why?
|
Hemangioma | 1 | 2023 | 727 | 0.160 |
Why?
|
Limb Salvage | 1 | 2021 | 466 | 0.150 |
Why?
|
Granuloma, Plasma Cell | 1 | 2019 | 80 | 0.150 |
Why?
|
Chromatin | 4 | 2024 | 2939 | 0.150 |
Why?
|
Facial Bones | 1 | 2019 | 205 | 0.150 |
Why?
|
Fractures, Spontaneous | 1 | 2019 | 231 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4024 | 0.150 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2018 | 93 | 0.150 |
Why?
|
Clinical Competence | 1 | 2013 | 4786 | 0.150 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 302 | 0.150 |
Why?
|
14-3-3 Proteins | 1 | 2018 | 221 | 0.140 |
Why?
|
Biopsy, Needle | 2 | 2019 | 1633 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 7 | 2018 | 36247 | 0.140 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 77 | 0.140 |
Why?
|
Central Cord Syndrome | 1 | 2016 | 5 | 0.140 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1423 | 0.140 |
Why?
|
Retrospective Studies | 13 | 2024 | 80301 | 0.140 |
Why?
|
Interferons | 1 | 2020 | 705 | 0.140 |
Why?
|
Neoplasms | 3 | 2022 | 22066 | 0.140 |
Why?
|
Adolescent | 15 | 2021 | 87747 | 0.140 |
Why?
|
Otitis Media | 1 | 2018 | 285 | 0.130 |
Why?
|
Hand Bones | 1 | 2016 | 13 | 0.130 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2020 | 633 | 0.130 |
Why?
|
Curettage | 1 | 2016 | 73 | 0.130 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2016 | 43 | 0.130 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 503 | 0.130 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14656 | 0.130 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2017 | 167 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 679 | 0.130 |
Why?
|
Immunoenzyme Techniques | 2 | 2016 | 1705 | 0.130 |
Why?
|
Disease-Free Survival | 2 | 2023 | 6830 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2927 | 0.130 |
Why?
|
Radius | 1 | 2019 | 440 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 82 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 9274 | 0.130 |
Why?
|
Pancreatectomy | 1 | 2020 | 809 | 0.120 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 169 | 0.120 |
Why?
|
Melanoma | 1 | 2013 | 5695 | 0.120 |
Why?
|
Fatal Outcome | 3 | 2018 | 1833 | 0.120 |
Why?
|
Temporal Bone | 1 | 2018 | 683 | 0.110 |
Why?
|
Lung | 3 | 2022 | 9989 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1180 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2019 | 2500 | 0.110 |
Why?
|
Pleural Neoplasms | 1 | 2019 | 609 | 0.110 |
Why?
|
Acromioclavicular Joint | 1 | 2013 | 76 | 0.100 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2805 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2877 | 0.100 |
Why?
|
RNA, Viral | 1 | 2021 | 2837 | 0.100 |
Why?
|
Histones | 2 | 2020 | 2583 | 0.100 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2015 | 1090 | 0.100 |
Why?
|
Adipose Tissue | 1 | 2024 | 3293 | 0.100 |
Why?
|
Pattern Recognition, Automated | 1 | 2018 | 988 | 0.100 |
Why?
|
Brain Diseases | 1 | 2021 | 1540 | 0.100 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2015 | 549 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1892 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2415 | 0.090 |
Why?
|
Tendinopathy | 1 | 2013 | 171 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2138 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11141 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 716 | 0.090 |
Why?
|
Osteoblasts | 1 | 2016 | 1142 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3735 | 0.090 |
Why?
|
Bone and Bones | 2 | 2022 | 2560 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1030 | 0.090 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 2056 | 0.090 |
Why?
|
Radiology | 1 | 2023 | 2103 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10185 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 935 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2021 | 64947 | 0.080 |
Why?
|
Child | 10 | 2023 | 79758 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1166 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2978 | 0.070 |
Why?
|
Child, Preschool | 6 | 2019 | 42034 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3758 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20048 | 0.070 |
Why?
|
Papillomaviridae | 1 | 2013 | 1117 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 5 | 2018 | 20484 | 0.070 |
Why?
|
Autopsy | 2 | 2021 | 1007 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2015 | 2007 | 0.070 |
Why?
|
Immunotherapy | 1 | 2022 | 4637 | 0.070 |
Why?
|
Oncogenes | 2 | 2022 | 1221 | 0.060 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 16905 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3764 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4374 | 0.060 |
Why?
|
Infant | 4 | 2019 | 36030 | 0.060 |
Why?
|
Postoperative Complications | 1 | 2007 | 15680 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2018 | 2880 | 0.060 |
Why?
|
Cohort Studies | 2 | 2019 | 41317 | 0.060 |
Why?
|
Epithelial Cells | 2 | 2020 | 3665 | 0.060 |
Why?
|
Fibroblasts | 1 | 2014 | 4091 | 0.060 |
Why?
|
Survival Rate | 4 | 2021 | 12806 | 0.060 |
Why?
|
WT1 Proteins | 1 | 2024 | 184 | 0.060 |
Why?
|
Carcinoma | 1 | 2015 | 2334 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3784 | 0.050 |
Why?
|
Binding Sites | 2 | 2023 | 6050 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6457 | 0.050 |
Why?
|
Mediastinum | 1 | 2023 | 265 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4739 | 0.050 |
Why?
|
Coloring Agents | 1 | 2024 | 561 | 0.050 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3618 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13629 | 0.040 |
Why?
|
Desmin | 1 | 2020 | 99 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39254 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 150 | 0.040 |
Why?
|
Massachusetts | 1 | 2013 | 8805 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 653 | 0.040 |
Why?
|
Muscle Cells | 1 | 2020 | 195 | 0.040 |
Why?
|
Contrast Media | 3 | 2017 | 5301 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2023 | 11480 | 0.040 |
Why?
|
Florida | 1 | 2020 | 427 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2019 | 102 | 0.040 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2811 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 329 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1612 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 232 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4215 | 0.040 |
Why?
|
Protein Stability | 1 | 2020 | 566 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2019 | 473 | 0.040 |
Why?
|
RNA Stability | 1 | 2020 | 332 | 0.040 |
Why?
|
Mucins | 1 | 2020 | 568 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 556 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 697 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2015 | 6131 | 0.030 |
Why?
|
Pinch Strength | 1 | 2016 | 4 | 0.030 |
Why?
|
Fibula | 1 | 2019 | 265 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2017 | 2633 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 718 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6545 | 0.030 |
Why?
|
Gene Fusion | 1 | 2019 | 354 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2007 | 1287 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3584 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1327 | 0.030 |
Why?
|
Pelvic Neoplasms | 1 | 2018 | 248 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 772 | 0.030 |
Why?
|
Iopamidol | 1 | 2016 | 186 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1740 | 0.030 |
Why?
|
Thoracic Neoplasms | 1 | 2018 | 265 | 0.030 |
Why?
|
Laminectomy | 1 | 2016 | 224 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2019 | 568 | 0.030 |
Why?
|
Protein Transport | 1 | 2020 | 1966 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2019 | 586 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 998 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 729 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1387 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3278 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2020 | 1120 | 0.030 |
Why?
|
Piperazines | 1 | 2024 | 2520 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 747 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.030 |
Why?
|
Myocarditis | 1 | 2021 | 766 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2945 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 956 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15273 | 0.030 |
Why?
|
Actins | 1 | 2020 | 2049 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2022 | 1529 | 0.030 |
Why?
|
Shoulder Pain | 1 | 2013 | 147 | 0.030 |
Why?
|
Extremities | 1 | 2018 | 867 | 0.030 |
Why?
|
Electromyography | 1 | 2017 | 1386 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6378 | 0.030 |
Why?
|
Phenotype | 2 | 2020 | 16543 | 0.020 |
Why?
|
Postural Balance | 1 | 2016 | 617 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2021 | 2441 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2668 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3323 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 749 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2003 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3537 | 0.020 |
Why?
|
SEER Program | 1 | 2016 | 1532 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2008 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2016 | 978 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2368 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1890 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2015 | 1305 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2721 | 0.020 |
Why?
|
Radiotherapy | 1 | 2015 | 1505 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2823 | 0.020 |
Why?
|
Accidental Falls | 1 | 2016 | 1054 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9336 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 4980 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4688 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4168 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17766 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5039 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6413 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9282 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3531 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6775 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5745 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81216 | 0.020 |
Why?
|
Anticoagulants | 1 | 2021 | 4896 | 0.020 |
Why?
|
Mutation | 2 | 2020 | 29950 | 0.020 |
Why?
|
DNA | 1 | 2019 | 7236 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9388 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10434 | 0.010 |
Why?
|
Glucose | 1 | 2015 | 4361 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3217 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9590 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4044 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4312 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3613 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7592 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12532 | 0.010 |
Why?
|
Animals | 2 | 2024 | 167940 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15766 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40133 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 12762 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15687 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74269 | 0.010 |
Why?
|
United States | 1 | 2016 | 72363 | 0.000 |
Why?
|